DELIC Labs is a licensed cannabis and psilocybin research laboratory focused on chemical process development, analytical testing, and extraction optimization. We are dedicated to bringing a rigorous scientific foundation to the cannabis and psilocybin industries through our innovative research initiatives and consulting services. We offer a wide range of scientific services and expertise involving all aspects of chemistry.
To advance the cannabis and psilocybin industry through collaborative research and fundamental science.
The founding team of DELIC Labs (formerly Complex Biotech Discovery Ventures) originates from research groups at world-renowned academic institutions. This background instilled an ethos of intellectual curiosity and aspirations of understanding complex concepts through experimentation, research, and analysis. Entering the cannabis industry early on, we were exposed to the dogmatic approaches to production and growth, where firms focused solely on lofty goals while lacking the imperative processes to achieve them. We choose to operate in contrast to that industry, utilizing the latest academic literature to develop strong processes that foster repeatable success. We reject traditional corporate hierarchies that impede progress by creating a multidisciplinary team of experts that contribute equally to generating novel solutions grounded in science.
DELIC Labs is the world’s leading company for chemical research and extraction expertise of controlled biopharmaceuticals.
Everyone on our diverse team has opportunities to contribute ideas and take action. We treat each other with respect and celebrate our different viewpoints, abilities, and accomplishments.
Our team works together toward our common goals as a company. We each do our best to ensure the company succeeds and expect the same from others.
We support each team member in their personal growth through activities such as debate, research, and conferences. We value education, grow from our mistakes, and actively participate in life-long learning.
We engage in meaningful discussions with each other and our partners to achieve superior performance. Being open and honest is vital for successful collaboration.
To solve the current and future problems of the cannabis and psilocybin industries, we utilize our talented team and collaborative relationships with partner organizations, industry leaders, and academia. These collaborative efforts enable us to expand our knowledge on complex subjects and work on a wide array of chemistry and business problems. We are committed to broadening our horizons by dedicating a fifth of our work time to acquiring knowledge from fields outside of our domain, ultimately building a stronger foundation of expertise for the company. We all actively participate in intellectual conversations with each other to better understand our projects and empower team members to learn from open discussions.
Dr. Markus Roggen
President and Chief Scientific Officer
DELIC Labs was initially founded as Complex Biotech Discovery Ventures by Dr. Roggen and Prof. Dr. Glenn Sammis in 2018, and rebranded after the sale to DELIC Corp.
Dr. Roggen received his M/Sci degree from Imperial College, London, UK in 2008. He then pursued his graduate degree in organic chemistry at the Federal Institute of Technology in Zürich (ETHZ), where he received his PhD in 2012. Dr. Roggen was awarded an DAAD postdoctoral fellowship to pursue further training in physical organic chemistry at The Scripps Research Institute in La Jolla from 2013-2014. He then entered the cannabis industry in 2014 and since has held executive position in analytical and production companies. His research into process optimization and analytical methods has been recognized with a number of awards, ElSohley Award of the ACS, Cannabis Scientist Power List 2020 & 2021, 40 under 40 by Marijuana Venture Magazine among others. Dr. Roggen is also a trusted advisor and mentor to multiple startups, startup accelerators and organizations.
Professor Glenn Sammis
Dr. Sammis started his chemical education at Stanford University, receiving B.Sc. in Chemistry with Honors and Distinction in 1999. He then jointed Prof. Eric Jacobsen at Harvard University as an NSF Predoctoral fellow and obtained a Ph.D. in Chemistry in 2004. After, he moved to Princeton University for a two-year NIH postdoctoral fellowship with Prof. Erik Sorensen. Dr. Sammis is now a Associate Professor at the Chemistry Department at the University of British Columbia. He has built an internationally recognized research group working on the development of novel synthetic methods for the preparation of natural products and pharmaceuticals.
Collaborative research for fundamental breakthroughs
VP Business Operations
Kendra is an experienced Vice President of Operations with a demonstrated history of working in education management and biotechnology industries. Skilled in Biotechnology, Project Manger in Life Sciences. Strong community and social services professional with a desire to improve quality of life for all.
Sajni has a Bachelor of Science with a combined major in Chemistry and Biology from the University of British Columbia. She is research-driven with a passion for cannabis science. Sajni has helped secure DELIC Labs’ Cannabis Analytical Testing License.
Dr. Eric Janusson
Dr. Eric Janusson is an analytical organometallic chemist specializing in real-time methods for the quantification and characterization of sensitive chemical intermediates. A long-time resident of Vancouver Island, Dr. Janusson received his Ph.D. in analytical chemistry at the University of Victoria in 2017 under the direction of Professor Scott McIndoe. After completing his studies, Dr. Janusson held a postdoctoral scholar position with the Cronin Group at the University of Glasgow where he developed an interest in machine learning, statistical modelling, self-assembly of inorganic nanoparticles, automated synthesis and robotics, as well as ion mobility mass spectrometry. Dr. Janusson is spearheading DELIC Labs’ analytical chemistry efforts and further developing high-quality analytical methods for cannabis and psilocybin research.
Dr. Tom Dupree
Dr. Dupree has a Ph.D in Computational Medicinal Chemistry from the University of New South Wales. Dr. Dupree guides the Data Analytics team by combining chemistry, machine learning, and statistics to develop DELIC Labs’ proprietary extraction optimization platform. He also helps clients with molecular modelling needs by leveraging his knowledge in computational chemistry.
Brodie is a current Ph.D candidate in Organic Chemistry at the University of British Columbia. He completed his Masters in Chemistry at the University of St. Andrews in Scotland before moving to Canada. At DELIC Labs, Brodie brings his expertise in method development and research to developing protocols for analyzing aerosol and volatile compounds found within cannabis smoke.